SCHEMBL8029952

SCHEMBL8029952

N#Cc1c(N)nc(OCc2coc(-c3ccc(Cl)cc3)n2)c(C#N)c1-c1ccc(CCCO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 11/20 0.43
▸ SLC6A3 Q01959 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HTT P42858 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ FFAR1 O14842 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12163910 0.90 ADORA1 (0.43) ADORA1SLC6A3KDM4EMAPTHSD17B10
SCHEMBL12164096 0.88 ADORA1 (0.39) ADORA1SLC6A3KDM4EMAPTHSD17B10
SCHEMBL382471 0.88 ADORA1 (0.51) ADORA1SLC6A3KDM4EMAPTHSD17B10
SCHEMBL12163801 0.88 PPARA (0.36) ADORA1SLC6A3KDM4EHSD17B10MEN1
SCHEMBL10194492 0.82 ADORA1 (0.54) ADORA1SLC6A3KDM4EMAPTHSD17B10
SCHEMBL10195690 0.82 PPARA (0.42) KDM4EMAPTALDH1A1LMNAFFAR1
SCHEMBL1931420 0.82 ADORA1 (0.41) ADORA1SLC6A3KDM4EMAPTHSD17B10
SCHEMBL1931422 0.82 ADORA1 (0.41) ADORA1SLC6A3KDM4EMAPTHSD17B10
SCHEMBL10194194 0.81 PPARA (0.37) ADORA1KDM4EMAPTMEN1KMT2A
SCHEMBL383022 0.79 ADORA1 (0.46) ADORA1SLC6A3KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2235011-B1 SUBSTITUTED PYRROLO[2, 3-B]AND PYRAZOLO[3, 4-B]PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS Bayer Pharma AG (DE) 2012-01-25 — — EP disclosed
EP-2185550-B1 SUBSTITUTED ARYLOXAZOLES AND THE USE THEREOF Bayer Pharma AG (DE) 2011-11-02 — — EP disclosed
WO-2009080197-A1 SUBSTITUTED PYRROLO[2, 3-B] AND PYRAZOLO[3, 4-B] PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 — — WO disclosed
Send feedback